Efficacy and safety of Shenmayizhi decoction as an adjuvant treatment for vascular dementia: Study protocol for a randomized controlled trial

BACKGROUND: Vascular dementia (VaD) is the second most common cause of dementia. The treatment of VaD still remains a challenge so far. Traditional Chinese Herbal medicine is a promising therapy due to their multiple components and targets. Shenmayizhi decoction (SMYZD), a Chinese Herbal prescriptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huichan, Liu, Nanyang, Wei, Yun, Pei, Hui, Liu, Meixia, Diao, XueMei, Zhang, Huiqin, Li, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922576/
https://www.ncbi.nlm.nih.gov/pubmed/31852125
http://dx.doi.org/10.1097/MD.0000000000018326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922576/
https://www.ncbi.nlm.nih.gov/pubmed/31852125
http://dx.doi.org/10.1097/MD.0000000000018326

Ejemplares similares